Search results for "Digestive System"

showing 10 items of 1747 documents

Immunohistochemical Characterization of 130 Cases of Primary Hepatic Carcinomas

1987

Primary liver carcinoma (PLC) may express a certain number of markers. Here we communicate results of an analysis of five such markers (alpha-1-antitrypsin--AAT--, carcino-embryonic antigen --CEA--, alpha-fetoprotein --AFP--, and superficial --HBsAg-- and core --HBcAg-- antigens of hepatitis B virus) by means of PAP techniques in 130 cases of PLC, comparing the neoplastic tissue and the non-tumorous liver. Three variants of PLC are distinguished: hepatocarcinoma (HC) (108 cases); cholangiocarcinoma (CC) (19 cases); and three cases of hepatocholangiocarcinoma (HCC). AAT was positive in 29 HC, 2 HCC, and negative in all 19 CC. CEA appeared positive in 16 HC, 16 CC and only one HCC. AFP was po…

HBsAgPathologymedicine.medical_specialtyCarcinoma HepatocellularCirrhosismedicine.disease_causePathology and Forensic MedicineImmunoenzyme TechniquesAdenoma Bile DuctAntigenCarcinomamedicineHumansneoplasmsTumor markerHepatitis B virusHepatitis B Surface Antigensbusiness.industryLiver NeoplasmsCell Biologymedicine.diseaseHepatitis B Core AntigensImmunohistochemistrydigestive system diseasesCarcinoembryonic AntigenHBcAgalpha 1-AntitrypsinImmunohistochemistryalpha-FetoproteinsbusinessPathology - Research and Practice
researchProduct

Polyalbumin receptors, hepatitis B surface antigen (HBsAg), and HBsAg/IgM complexes in HBsAg positive patients with and without delta superinfection.

1985

Receptors for polymerized human albumin are found at high litres during high-level hepatitis B virus (HBV) replication and in small amounts in chronic low-level infection. Complexes between hepatitis B surface antigen (HBsAg) and IgM without specificity for HbsAg are expressed in a pattern similar to that of receptors. Anti-albumin antibodies could be involved in their formation. Delta infection depresses the synthesis of gene products of HBV. To assess whether delta modifies the expression of receptors on HBsAg and the level of HBsAg/IgM complexes, and if anti-albumin antibodies are actually part of the complex, we tested sera from 86 subjects with acute and chronic HBV infection. Our find…

HBsAgRadioimmunoassayEnzyme-Linked Immunosorbent AssayReceptors Cell SurfaceSerum Albumin HumanAntigen-Antibody ComplexHepatitis b surface antigenmedicine.disease_causeVirologymedicineHumansReceptorSerum AlbuminHepatitis B virusHepatitis B Surface AntigensbiologyAlbuminvirus diseasesReceptors AlbuminHepatitis BVirologydigestive system diseasesTiterInfectious DiseasesViral replicationImmunoglobulin MImmunologyAcute DiseaseChronic Diseasebiology.proteinAntibodyJournal of medical virology
researchProduct

The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HB s Ag), hepatitis-B-core-antigen (HB c Ag) and IgG for the classifi…

1975

Liver biopsies of patients with inflammatory liver diseases and clinically healthy HBsAg-carriers were examined for presence of intracellular HBsAg, HBcAg and IgG by direct immunofluorescence. The studies revealed the following results: 1. In most cases healthy HBsAg-carriers had HBsAg in the cytoplasm, but they did never show HBcAg in the nuclei of hepatocytes. 2. In the early phase some patients with HBsAg-positive acute hepatitis had HBcAg and/or HBsAg in their hepatocytes. In a normal course with complete recovery the immunoelimination may clear either phenomenon at variable stages of the disease. 3. Cases one year after complete recovery of acute virus B-hepatitis had no HB-components …

HBsAgVirusHepatitis B AntigensAntigenDrug DiscoverymedicineHumansDirect fluorescent antibodyGenetics (clinical)Cell NucleusHepatitismedicine.diagnostic_testbusiness.industryLiver cellvirus diseasesGeneral MedicineHepatitis Amedicine.diseasedigestive system diseasesHBcAgLiverVirus DiseasesImmunoglobulin GLiver biopsyAcute DiseaseCarrier StateChronic DiseaseImmunologyMolecular MedicinebusinessKlinische Wochenschrift
researchProduct

IgM-Antikörper gegen Hepatitis B core-Antigen (anti-HBc IgM) bei “gesunden” HBsAg-Trägern. Eine Verlaufsstudie bei 75 Fällen

1981

In 75 healthy HBsAg carriers with normal liver tissue who were followed over a four years period, anti-HBc IgM was determined by ELISA. 61 HBsAg carriers (81%) were positive for anti-HBc IgM at first investigation. 54 individuals demonstrated persistence of anti-HBc IgM, 7 became anti-HBc IgM-negative within the observation period. 12 persons were persistent anti-HBc IgM-negative, and 2 developed anti-HBc IgM of low quantities. 3 of 4 individuals with HBsAg clearance demonstrated a considerable decrease of anti-HBc IgM concentration. Although signs of liver damage or development of chronic liver diseases were not observed at the time of control biopsy the existence of anti-HBcIgM indicates …

HBsAgmedicine.diagnostic_testbiologybusiness.industryvirusesvirus diseasesRadioimmunoassayGeneral MedicineHepatitis Bmedicine.diseaseVirologydigestive system diseasesVirusHBcAgAntigenImmunoglobulin Mparasitic diseasesDrug DiscoveryBiopsyImmunologymedicinebiology.proteinMolecular MedicinebusinessGenetics (clinical)Klinische Wochenschrift
researchProduct

Prophylaxis and treatment of hepatitis B in immunocompromised patients.

2007

The literature on hepatitis B virus (HBV) in immunocompromised patients is heterogeneous and referred mainly to the pre-antivirals era. Today a rational approach to the problem of hepatitis B in these patients provides for: (a) the evaluation of HBV markers and of liver condition in all subjects starting immunosuppressive therapies (baseline), (b) the treatment with antivirals (therapy) of active carriers, (c) the pre-emptive use of antivirals (prophylaxis) in inactive carriers, especially if they are undergoing immunosuppressive therapies judged to be at high risk, (d) the biochemical and hepatitis B surface antigen (HBsAg) monitoring (or universal prophylaxis, in case of high risk immunos…

HBsAgmedicine.medical_specialtyHepatitis C virusmedicine.medical_treatmentLiver transplantationTransplantmedicine.disease_causeGastroenterologyAntiviral AgentsImmunocompromised HostAnimals; Antiviral Agents; Carrier State; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Immunocompromised Host; Liver Transplantation; Tissue Donors; TransplantationAntivirals; HBV; Immunosuppression; Transplants;Internal medicineHBVMedicineAnimalsHumansAntiviralHepatitis B virusTransplantationHepatitis B Surface AntigensHepatologybusiness.industryGastroenterologyvirus diseasesHepatitis Bmedicine.diseaseHepatitis BHepatitis B Core Antigensdigestive system diseasesTissue DonorsLiver TransplantationTransplantationHBeAgImmunologyCarrier StateHepatitis D virusbusinessImmunosuppression
researchProduct

Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma

1992

In 1990, a case-control study was conducted in Italy to investigate the possible association between HCV infection and hepatocellular carcinoma (HCC). Serum samples from 65 subjects with newly diagnosed hepatocellular carcinoma and 99 hospital control subjects were tested for the presence of anti-HCV by second-generation ELISA test; positive sera were assayed by RIBA anti-HCV second-generation test. In addition, samples were tested for hepatitis B surface antigen (HBsAg), antibodies to the hepatitis B core antigen (anti-HBc), and antibodies to HBsAg (anti-HBs). The presence of HCV and/or HBsAg serologic markers was significantly associated with hepatocellular carcinoma risk: the relative ri…

HBsAgmedicine.medical_specialtyHepatologybusiness.industryHepatitis C virusvirus diseasesHepatitis Cmedicine.diseasemedicine.disease_causeGastroenterologydigestive system diseasesSerologyHepatocellular carcinomaRelative riskInternal medicineImmunologyAttributable riskMedicineRisk factorbusinessJournal of Hepatology
researchProduct

Sourdough Fermentation Degrades Wheat Alpha-Amylase/Trypsin Inhibitor (ATI) and Reduces Pro-Inflammatory Activity

2020

The ingestion of gluten-containing foods can cause wheat-related disorders in up to 15% of wheat consuming populations. Besides the role of gluten, &alpha

Health (social science)wheat sensitivity030309 nutrition & dieteticsPlant Sciencelcsh:Chemical technologyHealth Professions (miscellaneous)ACTIVATION0302 clinical medicineGLUTATHIONElcsh:TP1-1185Amylaseinnate immunityfermentation2. Zero hungerchemistry.chemical_classificationAMYLASE-TRYPSIN-INHIBITORS0303 health sciencesbiologydigestive oral and skin physiologyC100LACTOBACILLIfood and beveragesC500C700TrypsinBiochemistry030211 gastroenterology & hepatology3143 NutritionAlpha-amylaseCELIAC GLUTEN SENSITIVITYmedicine.drugProteasesINTESTINAL INFLAMMATIONPROTEINSTrypsin inhibitordigestive systemMicrobiologyArticle03 medical and health sciencesmedicineYEASTnutritional and metabolic diseasesGlutendigestive system diseasesYeastlactic acid bacteriaDOUGH416 Food Sciencechemistrybioactivitybiology.proteinFermentationPROLAMIN HYDROLYSISFood ScienceFoods
researchProduct

Immunological alterations in hepatitis C virus infection

2013

A higher prevalence of immunological processes has recently been reported in patients with hepatitis C virus (HCV) infection, focusing the attention of physicians and researchers on the close association between HCV and immune disorders. HCV lymphotropism represents the most important step in the pathogenesis of virus-related immunological diseases and experimental, virologic, and clinical evidence has demonstrated a trigger role for HCV both in systemic autoimmune diseases, such as rheumatoid arthritis, Sjogren syndrome, hemolytic anemia and severe thrombocytopenia, and in organ-specific autoimmune diseases, such as autoimmune hepatitis, thyroid disorders and diabetes. This review will out…

Hemolytic anemiaHepacivirusHepatitis C virusAutoimmunityAutoimmune hepatitisHepacivirusmedicine.disease_causeAutoimmunityAutoimmune DiseasesImmune systemmedicineAnimalsHumansTopic Highlightbiologybusiness.industryGastroenterologyAutoantibodyvirus diseasesGeneral MedicineHepatitis C Chronicmedicine.diseasebiology.organism_classificationVirologyHepatitis Cdigestive system diseasesRheumatoid arthritisImmunologybusiness
researchProduct

Internal sphincterotomy reduces postoperative pain after Milligan Morgan haemorrhoidectomy

2009

Abstract Background Over the last few years, there has been increasing attention on surgical procedures to treat haemorrhoids. The Milligan-Morgan haemorrhoidectomy is still one of the most popular surgical treatments of haemorrhoids. The aim of the present work is to assess postoperative pain, together with other early and late complications, after Milligan-Morgan haemorrhoidectomy as we could observe in our experience before and after performing an internal sphincterotomy. Methods from January 1980 to May 2007, we operated 850 patients, but only 699 patients (median age 53) were included in the present study because they satisfied our inclusion criteria. The patients were divided into two…

HemorrhoidectomyMalemedicine.medical_specialtyPostoperative painHemorrhoidectomy; Milligan Morgan; postoperative painlcsh:SurgeryAnal CanalHemorrhoidsMilligan MorganHemorrhoidsmedicineHumansDigestive System Surgical ProceduresPain PostoperativeAnal fissureMilligan morganbusiness.industrylcsh:RD1-811General MedicineMiddle AgedSurgical proceduresAnal canalmedicine.diseasehumanitiesSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureFemaleSurgerypostoperative painbusinessResearch ArticleBMC Surgery
researchProduct

Analysis of the precore DNA sequence and detection of precore antigen in liver specimens from patients with anti-hepatitis b e—positive chronic hepat…

1995

A number of naturally occurring hepatitis B virus (HBV) mutants unable to synthesize the hepatitis B e antigen (HBeAg) have been identified in patients characterized by HBV DNA and anti-HBe in their serum. Because the analysis of the HBV-associated DNA and antigens in the liver tissue is still not complete, we investigated the precore sequence of HBV DNA and its encoded proteins in the liver tissue of 32 patients positive for HBV DNA and anti-HBe in their serum. Three different groups of patients were identified. Group I (n = 14) was characterized by viral DNA sequences with a G-A transition in the distal precore gene region, thus creating a termination codon (TAG). Liver tissue from this g…

Hepatitis B virus0303 health sciencesHBsAgHepatologyvirus diseasesHepatitis BBiologymedicine.disease_causemedicine.diseaseVirologyMolecular biologydigestive system diseasesVirus3. Good healthlaw.invention03 medical and health sciencesHBcAg0302 clinical medicineHBeAglawmedicine030211 gastroenterology & hepatologyViral hepatitisPolymerase chain reaction030304 developmental biologyHepatology
researchProduct